NeuroSense Therapeutics
Ms. Diana Shtossel has over 15 years of vast knowledge and expertise in Regulatory Affairs and in all aspects of drug development throughout the product life cycle.
Ms. Shtossel has a significantt experience in development and registration of Drugs, Biologic Products, Combination Products and Medical Devices in US, EU, Canada, Israel and Rest of the World.
Previously, Ms. Shtossel held Regulatory Affairs Manager position at PolyPid and Regulatory Affairs Leader position at Omrix.
Ms. Shtossel holds an M.Sc. degree in Biology and M.B.A degree from Tel Aviv University.
This person is not in any offices
NeuroSense Therapeutics
NeuroSense Therapeutics is a clinical stage drug development company focusing on the development of a ground-breaking treatment for ALS patients, as well as other neurodegenerative diseases.